Xiaobing Jiang

机构：Union Hospital, Xi'an Medical University, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-2215-433X

发表论文 48 篇 · 总被引 993 次 · h-index 23

代表论文

• Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1 (2023 · Journal of Experimental & Clinical Cancer Research · 被引 55)
• Remodelling and Treatment of the Blood-Brain Barrier in Glioma (2021 · Cancer Management and Research · 被引 55)
• A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine (2021 · Cancer Letters · 被引 40)
• Long non-coding RNA OIP5-AS1 inhibition upregulates microRNA-129-5p to repress resistance to temozolomide in glioblastoma cells via downregulating IGF2BP2 (2021 · Cell Biology and Toxicology · 被引 35)
• LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification (2022 · Journal of Translational Medicine · 被引 32)
• EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma (2023 · Journal of Translational Medicine · 被引 30)